PROTOPORPHYRIA

Clinical trials for PROTOPORPHYRIA explained in plain language.

Never miss a new study

Get alerted when new PROTOPORPHYRIA trials appear

Sign up with your email to follow new studies for PROTOPORPHYRIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Liver drug study for rare disease pulled before it started

Disease control Terminated

This study aimed to see if the drug bitopertin is safe for people with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP) who also have early signs of liver disease. Researchers planned to check for side effects and measure changes in protoporphyrin levels in bl…

Matched conditions: PROTOPORPHYRIA

Phase: PHASE1 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control

Last updated Jun 27, 2026 09:00 UTC

PROTOPORPHYRIA

Get alerted when new PROTOPORPHYRIA trials appear

Liver drug study for rare disease pulled before it started